An hour may change everything for patients with lumbar spinal stenosis (LSS). Find out how this minimally invasive, outpatient procedure, which has a safety profile similar to an epidural steroid injection (ESI), may help you stand longer and walk farther with less pain.
Learn More
Pain or numbness in lower back when standing
Pain, numbness or tingling in legs or buttocks when walking
Relief when sitting or leaning forward
Help your LSS patients, even those with comorbidities, by removing a major root cause of their neurogenic claudication. Move to mild® to provide patients with long-term relief using a therapy that has a safety profile equivalent to an ESI, but with lasting results. Learn more about the minimally invasive mild® Procedure’s key benefits, clinical outcomes and how it can be incorporated into your treatment algorithm.
Learn MoreWhy is the Mild Procedure the Gold Standard of Care for lumbar spinal stenosis (#LSS)? It’s backed by EXTENSIVE EVIDENCE, including Level 1 data and real-world outcomes that offer a CLEAR CONSENSUS: Mild is the only LSS treatment with a safety profile equivalent to an injection and the lasting relief expected from back surgery.*
Put your patients on the path to lasting relief with the proven Mild Procedure, backed by:
• >30 peer-reviewed publications
• 2 Level 1 multicenter randomized controlled trials
• 16 clinical studies
• 5-year durability*
*View clinical data and learn more about the advantages of Mild at the #linkinbio.
Last weekend, we met with a group of Mild-trained physicians & Advanced Practice Providers (APPs) who were ready to disrupt the conventional algorithm for lumbar spinal stenosis (#LSS) and transform how and when they incorporate the Mild Procedure into their practice.
Thank you to our phenomenal faculty for leading this summit, Jason Pope, @evolverestorativecenter @krish_mdphd, @janeelizabeth77, @dr.khemlani, @ladypaindoc, @jamey_Lynch, @paiciusrick, @nvadvancedpain, and @paincsd. This group of experts has a combined 53 years of experience and has helped almost 1,000 patients gain access to the gold standard of care for LSS.
We look forward to making Mild accessible to even more of your peers and the millions of patients nationwide this year! Thank you to our attendees and faculty for your invaluable feedback and participation.
Help your lumbar spinal stenosis (#LSS) patients get back to things they love! With the Mild Procedure, patients typically resume normal activity within 24 hours with no restrictions, and are able to stand longer and walk farther with less pain.*
Make the #MOVE2mild earlier in your treatment algorithm to get your patients back in the game.
*Learn more and view clinical data at the #linkinbio.
@_dr.azeem
As an Advanced Practice Provider (APP), you are an integral part in helping patients with lumbar spinal stenosis (#LSS) get on the path to lasting relief.
Led by a panel of APP experts, join us for a Mild APP Workshop: “Establishing Expectations and Optimizing Outcomes” where we will discuss how patient education and proper outcomes assessment play an important role in optimizing patient outcomes after the Mild Procedure.
Join us May 25, 2022 to collaborate and learn from your peers on how to get the most for your Mild patients. Register at the #linkinbio.
Find your place on Team Vertos! With new positions available, we are excited to add to our growing team. Join us on our mission to help lumbar spinal stenosis (#LSS) patients get on the path to lasting relief.
View current openings available throughout the U.S. at the #linkinbio.
Vertos Medical is an Equal Employment Opportunity employer.
Advanced Practice Providers (APPs) play a vital role in helping patients understand their lumbar spinal stenosis (#LSS) diagnosis and treatment recommendations. By developing strong provider-patient communication, you’re taking the first step towards achieving positive outcomes and enhancing the patient experience.
In our latest blog, learn how APP @acomer3 uses her Mild Procedure Patient Brochure to help her LSS patients understand their condition and how the Mild Procedure can get them on the path to lasting relief.
View blog at the #linkinbio.
On #NationalNursesDay, we recognize the hardworking nurses and Advanced Practice Providers (APPs) who are helping lumbar spinal stenosis (#LSS) patients find lasting relief with the Mild Procedure.
Team Vertos thanks nurses everywhere for all that they do! 💜
The lumbar spinal stenosis (#LSS) treatment algorithm has been disrupted! If injections are falling short, move patients to the minimally invasive #MildProcedure.
Mild is the only treatment with a safety profile equivalent to an epidural steroid injection (ESI), and the lasting relief expected from back surgery.*
Our new patient brochure simplifies the patient education process, enabling you to illustrate LSS and where Mild fits among other treatment options. Learn more at the #linkinbio.
*Clinical data at the #linkinbio.
The Mild team is in motion!
We love being together to collaborate on the Mild Procedure and share knowledge, experience, and insights about how to help more practices #MOVE2mild. With this passionate group educating the community about Mild as the gold standard of care and supporting practices in making Mild their first-line therapy for lumbar spinal stenosis (#LSS), there's never been more momentum around Mild.
Thanks to this team, more and more LSS patients will be able to get back on their feet, and on the path to lasting relief.
"There may be patients in our practice who think that there are no other treatment options and very well may be a Mild candidate. Now, we can move away from doing multiple injections, especially if they’re not working, because those injections are not treating the underlying cause." Dr. Shawn Puri.
View the case study at the #linkinbio and make the #MOVE2mild in your practice.
How do you describe the Mild Procedure to patients? Dr. Erin Chaney of Jacksonville, NC says, “Imagine a room full of tables and chairs, and you just can't move around. What I am going to do today is just take a couple of chairs out to make some more space, so your anatomical structures can move around easily.”
The Mild Procedure leaves no implants behind, only a Band-Aid, allowing patients to get back on their feet doing what they love.
For more analogies from leading Mild physicians, check out our latest blog post at the #linkinbio.
There’s never been more momentum behind the #MildProcedure! Why are more practices and patients making the #MOVE2mild?
Mild is the Gold Standard of Care for lumbar spinal stenosis (#LSS) after conservative therapy fails and is backed by extensive evidence, including Level 1 data and real-world outcomes.*
The consensus is clear: It’s time to make Mild your first-line therapy for LSS and help your LSS patients get back on their feet and on the path to lasting relief.
*Learn more and view clinical data at the #linkinbio.
Is your practice optimized to get the most impact from the Mild Procedure?
Make sure your practice is using the latest patient education content in your reception areas, patient exam rooms, and on your website. Share Mild education tools with referring providers. By increasing awareness of the Mild Procedure in your community, you can help more lumbar spinal stenosis (#LSS) patients get on the path to lasting relief.
Contact your Vertos Medical representative for copies of the latest practice and patient education materials.
Attention Mild Practices—Can you spot the shopping cart syndrome for lumbar spinal stenosis (#LSS) patients? Do you look for the ligament? According to our Advanced Practice Provider (APP) Advisory Board, Mild Procedure patient identification is simple, and practice makes perfect when it comes to image review.
Click the #linkinbio for a quick overview and resources to optimize Mild patient identification and education.
Look for the ligament, it's a common problem, even in patients with comorbidities. Remove the problem with Mild and leave nothing behind.
*Clinical data at the #linkinbio.
Welcome to Team Vertos! We are proud to announce our newest members and have them join us in striving to offer safe, effective solutions to the lumbar spinal stenosis (#LSS) community.
Welcome to our new Regional Sales Director, Bryan Jones, District Sales Managers, Dana Maradie and Ryan Folsom, Sales Operations Manager, Cora Wolfarth, Talent Acquisition Manager, Anthony Incontro, Clinical Training Specialist, Justice Oates, and IT Technician, Andy Rivera.
Interested in joining our team? Click the #linkinbio for employment opportunities.
Benyamin RM, Staats PS, MiDAS ENCORE Investigators. mild® is an effective treatment for lumbar spinal stenosis with neurogenic claudication: MiDAS ENCORE Randomized Controlled Trial. Pain Physician. 2016;19(4):229-242.
Mekhail N, Costandi S, Abraham B, Samuel SW. Functional and patient-reported outcomes in symptomatic lumbar spinal stenosis following percutaneous decompression. Pain Pract. 2012;12(6):417-425. doi:10.1111/j.1533-2500.2012.00565.x.
2012 data from Health Market Sciences report for Vertos Medical 2013.
Data on file with Vertos Medical.
Staats PS, Chafin TB, Golvac S, et al. Long-term safety and efficacy of minimally invasive lumbar decompression procedure for the treatment of lumbar spinal stenosis with neurogenic claudication: 2-year results of MiDAS ENCORE. Reg Anesth Pain Med. 2018;43:789-794. doi:10.1097/AAP.0000000000000868.
Based on mild® Procedure data collected in all clinical studies. Major complications are defined as dural tear and blood loss requiring transfusion.
MiDAS ENCORE responder data. On file with Vertos Medical.
Jain S, Deer TR, Sayed D, et al. Minimally invasive lumbar decompression: a review of indications, techniques, efficacy and safety. Pain Manag. 2020;10(5). https://doi.org/10.2217/pmt-2020-0037. Accessed June 1, 2020.
Deer TR, Grider JS, Pope JE, et al. The MIST Guidelines: the Lumbar Spinal Stenosis Consensus Group guidelines for minimally invasive spine treatment. Pain Pract. 2019;19(3)250-274. doi:10.1111/papr.12744.
Hansson T, Suzuki N, Hebelka H, Gaulitz A. The narrowing of the lumbar spinal canal during loaded MRI: the effects of the disc and ligamentum flavum. Eur Spine J. 2009;18(5):679-686. doi:10.1007/s00586-009-0919-7.
Treatment options shown are commonly offered once conservative therapies (e.g., physical therapy, pain medications, chiropractic) are not providing adequate relief. This is not intended to be a complete list of all treatments available. Doctors typically recommend treatments based on their safety profile, typically prioritizing low risk/less aggressive procedures before higher risk/more aggressive procedures, but will determine which treatments are appropriate for their patients.
Although the complication rate for the mild® Procedure is low, as with most surgical procedures, serious adverse events, some of which can be fatal, can occur, including heart attack, cardiac arrest (heart stops beating), stroke, and embolism (blood or fat that migrates to the lungs or heart). Other risks include infection and bleeding, spinal cord and nerve injury that can, in rare instances, cause paralysis. This procedure is not for everyone. Physicians should discuss potential risks with patients. For complete information regarding indications for use, warnings, precautions, and methods of use, please reference the devices’ Instructions for Use.
Patient stories on this website reflect the results experienced by individuals who have undergone the mild® Procedure. Patients are not compensated for their testimonial. The mild® Procedure is intended to treat lumbar spinal stenosis (LSS) caused by ligamentum flavum hypertrophy. Although patients may experience relief from the procedure, individual results may vary. Individuals may have symptoms persist or evolve or other conditions that require ongoing medication or additional treatments. Please consult with your doctor to determine if this procedure is right for you.
Reimbursement, especially coding, is dynamic and changes every year. Laws and regulations involving reimbursement are also complex and change frequently. Providers are responsible for determining medical necessity and reporting the codes that accurately describe the work that is done and the products and procedures that are furnished to patients. For this reason, Vertos Medical strongly recommends that you consult with your payers, your specialty society, or the AMA CPT regarding coding, coverage and payment.
Vertos Medical cannot guarantee coding, coverage, or payment for products or procedures. View our Billing Guide.
Vertos is an equal employment opportunity workplace committed to pursuing and hiring a diverse workforce. We strive to grow our team with highly skilled people who share our culture and values. All qualified applicants will receive consideration for employment without regard to sex, age, color, race, religion, marital status, national origin, ancestry, sexual orientation, gender identity, physical & mental disability, medical condition, genetic information, veteran status, or any other basis protected by federal, state or local law.
Hall S, Bartleson JD, Onofrio BM, Baker HL Jr, Okazaki H, O’Duffy JD. Lumbar spinal stenosis. Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med. 1985;103(2):271-275. doi:10.7326/0003-4819-103-2-271.
Kalichman L, Cole R, Kim DH, et al. Spinal stenosis prevalence & association with symptoms: The Framingham Study. Spine J. 2009;9(7):545-550. doi:10.1016/j.spinee.2009.03.005.
Fukusaki M, Kobayashi I, Hara T, Sumikawa K. Symptoms of spinal stenosis do not improve after epidural steroid injection. Clin J Pain. 1998;14(2):148-151. doi:10.1097/00002508-199806000-00010.
Mekhail N, Costandi S, Nageeb G, Ekladios C, Saied O. The durability of minimally invasive lumbar decompression procedure in patients with symptomatic lumbar spinal stenosis: Long-term follow-up [published online ahead of print, 2021 May 4]. Pain Pract. 2021;10.1111/papr.13020. doi:10.1111/papr.13020
Friedly JL, Comstock BA, Turner JA, et al. Long-Term Effects of Repeated Injections of Local Anesthetic With or Without Corticosteroid for Lumbar Spinal Stenosis: A Randomized Trial. Arch Phys Med Rehabil. 2017;98(8):1499-1507.e2. doi:10.1016/j.apmr.2017.02.029
Pope J, Deer TR, Falowski SM. A retrospective, single-center, quantitative analysis of adverse events in patients undergoing spinal stenosis with neurogenic claudication using a novel percutaneous direct lumbar decompression strategy. J Pain Res. 2021;14:1909-1913. doi: 10.2147/JPR.S304997
Pryzbylkowski P, Bux A, Chandwani K, et al. Minimally invasive direct decompression for lumbar spinal stenosis: impact of multiple prior epidural steroid injections [published online ahead of print, 2021 Aug 4]. Pain Manag. 2021;10.2217/pmt-2021-0056. doi:10.2217/pmt-2021-0056
Abstract presented at: American Society of Pain and Neuroscience Annual Conference; July 22-25, 2021; Miami Beach, FL.
